Inhibitory activities of the marine streptomycete-derived compound SF2446A2 against Chlamydia trachomatis and Schistosoma mansoni (original) (raw)

References

  1. Somani, J., Bhullar, V. B., Workowski, K. A., Farshy, C. E. & Black, C. M. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J. Infect. Dis. 181, 1421–1427 (2000).
    Article CAS Google Scholar
  2. Stephens, R. S. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol. 11, 44–51 (2003).
    Article CAS Google Scholar
  3. Sharma, M. & Rudel, T. Apoptosis resistance in Chlamydia-infected cells: a fate worse than death? FEMS Immunol. Med. Microbiol. 55, 154–161 (2009).
    Article CAS Google Scholar
  4. Beatty, W. L., Morrison, R. P. & Byrne, G. I. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev. 58, 686–699 (1994).
    CAS PubMed PubMed Central Google Scholar
  5. Hogan, R. J., Mathews, S. A., Mukhopadhyay, S., Summersgill, J. T. & Timms, P. Chlamydial persistence: beyond the biphasic paradigm. Infect. Immun. 72, 1843–1855 (2004).
    Article CAS Google Scholar
  6. World Health Organization Schistosomiasis. Fact sheet N° 115, (2013). Available from http://www.who.int/mediacentre/factsheets/fs115/en/ (accessed February 2014).
  7. Fallon, P. G. Immunopathology of schistosomiasis: a cautionary tale of mice and men. Immunol. Today 21, 29–35 (2000).
    Article CAS Google Scholar
  8. Doenhoff, M. J., Cioli, D. & Utzinger, J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr. Opin. Infect. Dis. 21, 659–667 (2008).
    Article CAS Google Scholar
  9. Fenical, W. & Jensen, P. R. Developing a new resource for drug discovery: marine actinomycete bacteria. Nat. Chem. Biol. 2, 666–673 (2006).
    Article CAS Google Scholar
  10. Abdelmohsen, U. R., Bayer, K. & Hentschel, U. Diversity, abundance and natural products of marine sponge-associated actinomycetes. Nat. Prod. Rep. 31, 381–399 (2014).
    Article CAS Google Scholar
  11. Eltamany, E. E. et al. New antibacterial xanthone from the marine sponge-derived Micrococcus sp. EG45. Bioorg. Med. Chem. Lett. 24, 4939–4942 (2014).
    Article CAS Google Scholar
  12. Pimentel-Elardo, S. M. et al. Anti-parasitic compounds from Streptomyces sp. strains isolated from Mediterranean sponges. Mar. Drugs 8, 373–380 (2010).
    Article CAS Google Scholar
  13. Mayer, A. M. & Hamann, M. T. Marine pharmacology in 2001—2002: marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. Toxicol. Pharmacol. 140, 265–286 (2005).
    Article Google Scholar
  14. Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. & Prinsep, M. R. Marine natural products. Nat. Prod. Rep. 30, 237–323 (2013).
    Article CAS Google Scholar
  15. Abdelmohsen, U. R. et al. Antioxidant and anti-protease activities of diazepinomicin from the sponge-associated Micromonospora strain RV115. Mar. Drugs 10, 2208–2221 (2012).
    Article CAS Google Scholar
  16. Bull, A. T. & Stach, J. E. Marine actinobacteria: new opportunities for natural product search and discovery. Trends Microbiol. 15, 491–499 (2007).
    Article CAS Google Scholar
  17. Solanki, R., Khanna, M. & Lal, R. Bioactive compounds from marine actinomycetes. Indian J. Microbiol. 48, 410–431 (2008).
    Article CAS Google Scholar
  18. Subramani, R. & Aalbersberg, W. Marine actinomycetes: an ongoing source of novel bioactive metabolites. Microbiol. Res. 167, 571–580 (2012).
    Article CAS Google Scholar
  19. Tiwari, K. & Gupta, R. K. Rare actinomycetes: a potential storehouse for novel antibiotics. Crit. Rev. Biotechnol. 32, 108–132 (2012).
    Article CAS Google Scholar
  20. Takeda, U. et al. SF2446, new benzo[a]naphthacene quinone antibiotics. I. Taxonomy and fermentation of the producing strain, isolation and characterization of antibiotics. J. Antibiot. (Tokyo) 41, 417–424 (1988).
    Article CAS Google Scholar
  21. Abdelmohsen, U. R. et al. Isolation, phylogenetic analysis and anti-infective activity screening of marine sponge-associated actinomycetes. Mar. Drugs 8, 399–412 (2010).
    Article CAS Google Scholar
  22. Wang, Y. et al. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog. 7, e1002258 (2011).
    Article CAS Google Scholar
  23. Appendix A to the European Convention for the Protection of Vertebrate Animals used for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes ETS No.123) Guidelines for accommodation and care of animals (Article 5 of the Convention) http://conventions.coe.int/Treaty/EN/Treaties/Html/123-A.htm (accessed 24 April 2015).
  24. Grevelding, C. G. The female-specific W1 sequence of the Puerto Rican strain of Schistosoma mansoni occurs in both genders of a Liberian strain. Mol. Biochem. Parasitol. 71, 269–272 (1995).
    Article CAS Google Scholar
  25. Beckmann, S., Leutner, S., Gouignard, N., Dissous, C. & Grevelding, C. G. Protein kinases as potential targets for novel anti-schistosomal strategies. Curr. Pharm. Des 18, 3579–3594 (2012).
    CAS PubMed Google Scholar
  26. Gomi, S., Sasaki, T., Itoh, J. & Sezaki, M. SF2446, new benzo[a]naphthacene quinone antibiotics. II. The structural elucidation. J. Antibiot. (Tokyo) 41, 425–432 (1988).
    Article CAS Google Scholar

Download references